Peptides, without the noise.
Every peptide is a building block — find the one your body's missing. The clearest, most trustworthy guide to what the science and the FDA actually say. Then talk to a real provider.
What everyone is talking about
Updated October 1, 2026
- 1
Two big trials published in two days
Full TRIUMPH-1 results hit the New England Journal of Medicine on Sept 29 (25.0% average weight loss at the top dose, counting everyone) and TRIUMPH-2 in people with type 2 diabetes was presented at EASD on Sept 30. Still investigational; Lilly plans to file with the FDA in early 2027.
- 2
Closer to a legal compounding path
After an FDA advisory committee voted 8-6 in July to recommend it for the 503A Bulks List, people are watching for the FDA's next step. Human evidence is still thin (grade D), and no proposed rule had been published as of Oct 1.
Is BPC-157 legal in 2026? →Source: McDermott Will & Schulte: PCAC vote summary
- 3
The GLP-1 pill with no food rules
Approved April 1, 2026 and taken once a day without timing it around meals or water, it starts at $149 a month cash. Fun fact: it acts on the GLP-1 receptor but is a small molecule, not a peptide.
Compare GLP-1 prices →Source: diaTribe: Foundayo for weight loss
- 4
The copper peptide of skincare
A long-studied ingredient in serums for skin and hair, now buzzing on social media. Injectable GHK-Cu came off the FDA's restricted list in April 2026, with an advisory review expected by February 2027. Human evidence is still early (grade C).
See the GHK-Cu score →Source: FDA: Pharmacy Compounding Advisory Committee
- 5
Wegovy without the needle, from $149
The pill version of semaglutide, approved for weight management in December 2025, now starts at $149 a month cash through Novo's own pharmacy, the same price as the new Foundayo pill.
Compare GLP-1 prices →Source: NovoCare Pharmacy: Wegovy pill pricing
What is a peptide, really?
- 1
Amino acids are the blocks
Your body uses 20 kinds of amino acids. Think of each one as a building block.
- 2
A short chain is a peptide
Link 2 to about 50 of them and you get a peptide. Semaglutide is 31 blocks long; BPC-157 is 15.
- 3
It fits a receptor, like a key
The chain's shape matches a receptor on your cells and switches a signal on, such as "I'm full."
Many are copies of signals your body already makes, which is why some became FDA-approved medicines and others are still being studied. How GLP-1 peptides work →
What peptide medicine actually looks like
A weekly pen, or a daily pill
The best-known peptide medicines, like semaglutide and tirzepatide, come as a small injection pen. Some now come as a pill.
Made by licensed pharmacies
Brand-name drugs come from FDA-inspected manufacturers. Compounded versions come from licensed pharmacies, with a prescription.
Prescribed by a real clinician
In person or by video, a licensed provider decides what is appropriate. Never a website selling vials.
Start where you are
Legal Status
What's legal right now — tracked after every FDA & PCAC decision.
Open →GLP-1 & Weight
Semaglutide, tirzepatide, and the metabolic peptides, explained plainly.
Open →Peptide Library
Evidence-based profiles of every major peptide, with sources.
Open →Getting Access
Cost, telehealth, and how to find a legitimate provider.
Open →How Peptiblox works
The science, not the hype
Plain-English, sourced guides and a live legal tracker — so you actually understand what you’re reading about.
See what fits your goals
A quick diagnostic points you to the peptide category people with similar goals discuss with a provider.
Connect with a licensed provider
When you’re ready, we point you to licensed providers — never sellers or research-chemical sites.
Fresh from the blog
All articles →Retatrutide TRIUMPH-2 Results Explained (EASD 2026)
Full TRIUMPH-2 results for retatrutide in type 2 diabetes: up to 20.8% weight loss and A1C down up to 1.6 points at 80 weeks. What the numbers mean, plainly.
Retatrutide vs Tirzepatide vs Semaglutide (2026)
Retatrutide, tirzepatide and semaglutide compared honestly: mechanism, trial weight loss, side effects, and the big difference: only two are FDA-approved today.
What Is Retatrutide? The Triple-Agonist, Explained
Retatrutide is an investigational weekly injection that acts on three hormone receptors: GIP, GLP-1 and glucagon. How it works, what trials show, its status.